Evaluating Atock Dry Syrup for Children with Acute Bronchitis

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial assesses the efficacy and safety of Atock Dry Syrup in treating children aged 6 months to under 12 years who are experiencing acute bronchitis. Participants will be evaluated based on their bronchitis severity and wheezing scores, with some receiving the Atock Dry Syrup and others receiving a placebo. The study aims to determine whether the syrup can effectively alleviate symptoms of acute bronchitis in this pediatric population.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Children aged ≥6 months to \<12 years old
2. Total Bronchitis Severity Scale excluding sputum(BSSEs) ≥4
3. Wheezing score ≥2
4. Subjects who present symptoms of Acute Bronchitis within 48 hours from screening visit
5. Subject with negative results in HbsAg or HCV Ab test within 6 months from screening visit

Exclusion Criteria:

1. Subjects with chronic respiratory diseases (e.g., asthma, COPD) or severe respiratory diseases (e.g., pneumonia, cystic fibrosis, influenza, active tuberculosis)
2. Subjects under treatment with corticosteroids, antibiotics medications
3. Subjects with severe hepatic and renal impairment
4. Subjects with a history of drug abuse
5. Subject with positive results in HIV Ab test

Where it's running

• Soonchunhyang University Seoul Hospital
  Seoul, South Korea Recruiting

Study contacts

• Study coordinator: Hyeon Jong Yang, MD
• Email: ilove902@hanmail.net
• Phone: +82-2-709-9390

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Raphamin for acute bronchitis in adults

  This study tests whether Raphamin helps adults with acute bronchitis feel better faster compared with a placebo.

  Recruiting at 29 sites Phase 3 Materia Medica Holding · Aramil and 32 other locations · NCT07650227

• Shortening antibiotic courses for common throat and chest infections in primary care with doctor–pharmacist teamwork and viral‑circulation updates

  This project will test whether giving primary care doctors and pharmacists extra information about circulating viruses plus a shared protocol helps shorten antibiotic courses for patients with common respiratory infections.

  Recruiting University Hospital, Caen · Caen · NCT07359287

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.